Health ❯Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease Research Risk Factors Treatment Gender Differences Biomarkers Caregiving Amyloids Brain Cell Death Genetics RNA Interference SuperAgers Inflammation Pathways to Alzheimer's Brain Cell Loss Treatment Strategies Research Findings Posterior Cortical Atrophy Transmission of Alzheimer's Disease Early-Onset Alzheimer's Transmissible Dementia APOE4 Lipids APOE Protein Aggregates Gene Length Donanemab Genetic Risk Factors Research Institutions Vascular Contributions Preventative Strategies Social Behavior Immune System Cellular Stress Pathology Genetic Factors Drug Development Brain Regions Therapies Genetic Mutations Protein Aggregation Amyloid-Beta Aggregates Environmental Factors Drug Repurposing Amyloid Precursor Protein Brain Function Treatment Options Causes Viral Infections

Hibernation-Linked DNA Switches Discovered in Human Genome

These conserved regulatory switches offer new avenues for targeted therapies against diabetes, obesity, neurodegeneration

Study Reveals Genetic Origins of Multiple Brain Disorders in Early Fetal Development

Proteomics and Early Biomarkers Forge Personalized Paths in Alzheimer’s Detection

Bilardo No Longer Recognizes Anyone, Says Miguel Lemme

Global Proteomics Consortium Reveals Immune Signature and Disease-Specific Markers in Brain Disorders

Alzheimer’s Biomarkers Emerge in Middle Age With Maternal and Kidney Associations

Study Uncovers Cypin’s Synaptic Mechanisms, Fuels Efforts Toward Brain Disorder Treatments

Fiona Phillips Reveals Traumatic Strictly Memories Ahead of Memoir Launch

Christchurch Mutation Blocks cGAS-STING Pathway to Delay Alzheimer’s

Charities Unite to Fast-Track Alzheimer’s and Parkinson’s Treatments Through Drug Repurposing

Early Alzheimer’s Risk Linked to Increased Social Engagement

Lab-Grown Aged Neurons Reveal Molecular Stress as Driver of Neurodegeneration

STING molecule drives Alzheimer’s damage in mice, offering new therapeutic avenue

Framingham Study Links Blood Lipid Subtypes to Alzheimer's Risk

Étienne-Émile Baulieu, Inventor of RU-486, Dies at 98

Astrocytes Redefined as Key Regulators of Brain Function in Groundbreaking Studies

Nanotherapy Using Sugar-Coated Fibers Shows Promise in Combating Alzheimer’s and ALS

HIV Drugs Linked to Reduced Alzheimer’s Risk in Landmark Study

TDP-43 Protein Found to Drive Blood-Brain Barrier Breakdown in Neurodegenerative Diseases

Herpes Virus Linked to Alzheimer's Disease Progression